Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Stiegler, P; Bausys, A; Leber, B; Strupas, K; Schemmer, P.
Impact of Melatonin in Solid Organ Transplantation-Is It Time for Clinical Trials? A Comprehensive Review.
Int J Mol Sci. 2018; 19(11):
Doi: 10.3390/ijms19113509
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Schemmer Peter
-
Stiegler Philipp
- Co-Autor*innen der Med Uni Graz
-
Leber Bettina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Solid organ transplantation is the "gold standard" for patients with end-stage organ disease. However, the supply of donor organs is critical, with an increased organ shortage over the last few years resulting in a significant mortality of patients on waiting lists. New strategies to overcome the shortage of organs are urgently needed. Some experimental studies focus on melatonin to improve the donor pool and to protect the graft; however, current research has not reached the clinical level. Therefore, this review provides a comprehensive overview of the data available, indicating that clinical evaluation is warranted.
- Find related publications in this database (using NLM MeSH Indexing)
-
Graft Rejection - drug therapy
-
Graft Rejection - pathology
-
Humans -
-
Melatonin - therapeutic use
-
Organ Transplantation - trends
-
Time Factors -
-
Tissue Donors -
-
Tissue and Organ Procurement - trends
-
Waiting Lists -
- Find related publications in this database (Keywords)
-
heart transplantation
-
lung transplantation
-
liver transplantation
-
kidney transplantation
-
pancreas transplantation
-
melatonin
-
review